163 related articles for article (PubMed ID: 32705248)
1. oxLDL promotes podocyte migration by regulating CXCL16, ADAM10 and ACTN4.
Chen Y; Wang Z; Li Q; Yu L; Zhu Y; Wang J; Sun S
Mol Med Rep; 2020 Sep; 22(3):1976-1984. PubMed ID: 32705248
[TBL] [Abstract][Full Text] [Related]
2. oxLDL-induced lipid accumulation in glomerular podocytes: role of IFN-γ, CXCL16, and ADAM10.
Wang L; Sun S; Zhou A; Yao X; Wang Y
Cell Biochem Biophys; 2014 Sep; 70(1):529-38. PubMed ID: 24752304
[TBL] [Abstract][Full Text] [Related]
3. CXCL16 and oxLDL are induced in the onset of diabetic nephropathy.
Gutwein P; Abdel-Bakky MS; Doberstein K; Schramme A; Beckmann J; Schaefer L; Amann K; Doller A; Kämpfer-Kolb N; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
J Cell Mol Med; 2009 Sep; 13(9B):3809-25. PubMed ID: 19426159
[TBL] [Abstract][Full Text] [Related]
4. CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.
Gutwein P; Abdel-Bakky MS; Schramme A; Doberstein K; Kämpfer-Kolb N; Amann K; Hauser IA; Obermüller N; Bartel C; Abdel-Aziz AA; El Sayed el SM; Pfeilschifter J
Am J Pathol; 2009 Jun; 174(6):2061-72. PubMed ID: 19435795
[TBL] [Abstract][Full Text] [Related]
5. CXCL16 Promotes Gastric Cancer Tumorigenesis via ADAM10-Dependent CXCL16/CXCR6 Axis and Activates Akt and MAPK Signaling Pathways.
Han J; Fu R; Chen C; Cheng X; Guo T; Huangfu L; Li X; Du H; Xing X; Ji J
Int J Biol Sci; 2021; 17(11):2841-2852. PubMed ID: 34345211
[TBL] [Abstract][Full Text] [Related]
6. ADAM10-Mediated Ectodomain Shedding Is an Essential Driver of Podocyte Damage.
Sachs M; Wetzel S; Reichelt J; Sachs W; Schebsdat L; Zielinski S; Seipold L; Heintz L; Müller SA; Kretz O; Lindenmeyer M; Wiech T; Huber TB; Lüllmann-Rauch R; Lichtenthaler SF; Saftig P; Meyer-Schwesinger C
J Am Soc Nephrol; 2021 Jun; 32(6):1389-1408. PubMed ID: 33785583
[TBL] [Abstract][Full Text] [Related]
7. Effect of Simvastatin on Lipid Accumulation and the Expression of CXCL16 and Nephrin in Podocyte Induced by Oxidized LDL.
Wang L; Yao X; Li Q; Sun S
J Invest Surg; 2018 Apr; 31(2):69-74. PubMed ID: 28635512
[TBL] [Abstract][Full Text] [Related]
8. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16.
Gough PJ; Garton KJ; Wille PT; Rychlewski M; Dempsey PJ; Raines EW
J Immunol; 2004 Mar; 172(6):3678-85. PubMed ID: 15004171
[TBL] [Abstract][Full Text] [Related]
9. Enoxaparin prevents CXCL16/ADAM10-mediated cisplatin renal toxicity: Role of the coagulation system and the transcriptional factor NF-κB.
Aboyoussef AM; Abdel-Sattar AR; Abdel-Bakky MS; Messiha BAS
Life Sci; 2021 Apr; 270():119120. PubMed ID: 33545204
[TBL] [Abstract][Full Text] [Related]
10. CXCL16/ERK1/2 pathway regulates human podocytes growth, migration, apoptosis and epithelial mesenchymal transition.
Chen Y; Wang Z; Li Q; Tian M; Zhu Y; Yu L; Wang J; Sun S
Mol Med Rep; 2022 Jun; 25(6):. PubMed ID: 35514316
[TBL] [Abstract][Full Text] [Related]
11. P2X7 receptor inhibition attenuates podocyte injury by oxLDL through deregulating CXCL16.
Zhu Y; Li Q; Chen Y; Tian M; Xun W; Sun S
Cell Biol Int; 2022 Mar; 46(3):454-461. PubMed ID: 34882892
[TBL] [Abstract][Full Text] [Related]
12. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
[TBL] [Abstract][Full Text] [Related]
13. ADAM10-Interacting Tetraspanins Tspan5 and Tspan17 Regulate VE-Cadherin Expression and Promote T Lymphocyte Transmigration.
Reyat JS; Chimen M; Noy PJ; Szyroka J; Rainger GE; Tomlinson MG
J Immunol; 2017 Jul; 199(2):666-676. PubMed ID: 28600292
[TBL] [Abstract][Full Text] [Related]
14. The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.
Schramme A; Abdel-Bakky MS; Kämpfer-Kolb N; Pfeilschifter J; Gutwein P
Biochem Biophys Res Commun; 2008 May; 370(2):311-6. PubMed ID: 18373975
[TBL] [Abstract][Full Text] [Related]
15. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
[TBL] [Abstract][Full Text] [Related]
16. ADAM10-Initiated Release of Notch Intracellular Domain Regulates Microtubule Stability and Radial Migration of Cortical Neurons.
Yang Z; Li PF; Chen RC; Wang J; Wang S; Shen Y; Wu X; Fang B; Cheng X; Xiong ZQ
Cereb Cortex; 2017 Feb; 27(2):919-932. PubMed ID: 28158408
[TBL] [Abstract][Full Text] [Related]
17. Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Gutwein P; Schramme A; Sinke N; Abdel-Bakky MS; Voss B; Obermüller N; Doberstein K; Koziolek M; Fritzsche F; Johannsen M; Jung K; Schaider H; Altevogt P; Ludwig A; Pfeilschifter J; Kristiansen G
Eur J Cancer; 2009 Feb; 45(3):478-89. PubMed ID: 19070478
[TBL] [Abstract][Full Text] [Related]
18. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
19. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
Korbecki J; Bajdak-Rusinek K; Kupnicka P; Kapczuk P; Simińska D; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33800554
[TBL] [Abstract][Full Text] [Related]
20. Targeting ADAM10 in Renal Diseases.
Wang JN; Cao XJ
Curr Mol Med; 2023; 23(10):1037-1045. PubMed ID: 36278450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
